Summary
Japanese patients with peroxisomal disorders in the pediatric field were screened. Very long chain fatty acid analysis in the serum sphingomyelin was introduced since 1987 and was useful for the first screening of peroxisomal disorders. Seventy-five patients were diagnosed since 1980: 15 patients with Zellweger syndrome, 2 with neonatal adrenoleukodystrophy (ALD), 1 with rhizomelic chondrodysplasia punctata, 1 with Zellweger-like syndrome, 2 with acyl-CoA oxidase deficiency, 2 with bifunctional enzyme deficiency and 52 with X-linked ALD. The incidence of peroxisome-deficienct disorders was estimated to be approximately 1 in 800,000 births which is far less than that in the USA. However, the incidence in Okinawa Islands was 1 in 30,000. Japanese Zellweger patients belonged to 5 complementation groups (A, B, C, E, F) and the patients in Okinawa Islands belonged to groups A and C. The results of this screening were useful for genetic counseling, prenatal diagnosis, carrier detection and early medical care of patients with peroxisomal disorders.
Similar content being viewed by others
Article PDF
References
Asano J, Suzuki Y, Yajima S, Inoue K, Shimozawa I, Kondo N, Murase M, Orii T (1994): Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy. Brain Dev16: 454–458
Brown FR, McAdams AJ, Cummins JW, Konkol R, Singh I, Moser AB, Moser HW (1982): Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J151: 344–361
Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, Wisniewski HK, Ritch RH, Norton WT, Rapin I, Gartner LM (1973): Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science182: 62–64
Igarashi M, Schaumburg HH, Powers J, Kishimoto Y, Kolodney E, Suzuki K (1976): Fatty acid abnormality in adrenoleukodystrophy. J Neurochem26: 851–860
Lazarow PB, Moser HW (1995): Disorders, of peroxisome biogenesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2287–2324
Moser HW, Kok F, Neumann S, Borel J, Bergin A, Mostafa SD, Panosha R, Davoli CT, Shankroff J, Smith KD (1994): Adrenoleukodystrophy update: genetics and effect of Lorenzo's oil therapy in asymptomatic patients. Int Pediatr9: 196–204
Moser HW, Smith KD, Moser AB (1995): X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2325–2349
Schutgens RBH, Romeyn GJ, Wanders RJA, van den Bosch H, Schrakamp G, Heymans HSA (1984): Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hapato-renal) syndrome. Biochem Biophys Res Commun120: 179–184
Shimozawa N, Suzuki Y, Orii T, Moser A, Moser H, Wanders RJA (1993a): Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect. Am J Hum Genet52: 843–844
Shimozawa N, Suzuki Y, Orii T, Tsukamoto T, Fujiki Y (1993b): Prenatal diagnosis of Zellweger syndrome using DNA analysis. Prenatal Diagn13: 149
Suzuki Y, Orii T, Mori M, Tatibana M, Hashimoto T (1986): Deficient activities and proteins of peroxisomal β-oxidation enzymes in infants with Zellweger syndrome. Clin Chim Acta156: 191–196
Suzuki Y, Shimozawa N, Orii T, Igarashi N, Kono N, Matsui A, Inoue Y, Yokota S, Hashimoto T (1988): Zellweger-like syndrome with detectable hepatic peroxisomes: a variant form of peroxisomal disorder. J Pediatr113: 841–845
Suzuki Y, Yamaguchi S, Orii T, Tsuneoka M, Tashiro Y (1990): Nonspecific lipid transfer protein (sterol carrier protein-2) defective in patients with deficient peroxisomes. Cell Struct Funct15: 301–308
Suzuki Y, Shimozawa N, Yajima S, Yamaguchi S, Orii T, Hashimoto T (1991): Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases. Biochem Pharmacol41: 453–456
Suzuki Y, Shimozawa N, Yajima S, Tomatsu S, Kondo N, Nakada Y, Akaboshi S, Iai M, Tanabe Y, Hashimoto T, Wanders RJA, Schutgens RBH, Moser HW, Orii T (1994): Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis. Am J Hum Genet54: 36–43
Tsuji S, Suzuki M, Ariga T, Sekine M, Kuriyama M, Miyatake T (1981): Abnormality of long-chain fatty acids in, erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy. J Neurochem36: 1046–1049
Yajima S, Suzuki Y, Shimozawa N, Yamaguchi S, Orii T, Fujiki Y, Osumi T, Hashimoto T, Moser HW (1992): Complementation study of peroxisome-deficient, disorders by immunofluorescence staining and characterization of fused cells. Hum Genet88: 491–499
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, Y., Shimozawa, N., Yajima, S. et al. Incidence of peroxisomal disorders in Japan. Jap J Human Genet 41, 167–175 (1996). https://doi.org/10.1007/BF01892624
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01892624